Cardiovascular Diseases

Intensive BP Control Benefits T2D Patients

A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events among patients with type 2 diabetes (T2D) was significantly lower with intensive treatment targeting a systolic blood pressure (SBP) of less than 120 mm Hg than with standard treatment targeting a SBP of less than 140 mm Hg. A total of 12,821 T2D patients 50 years of age or older (mean age 63.8 years, 45.3% women; 6414 patients in the intensive-treatment group and 6407 in the standard-treatment group) were enrolled from February 2019 through December 2021. At 1 year of follow-up, the mean SBP was 121.6 (median, 118.3) mm Hg in the intensive-treatment group and 133.2 (median, 135.0) mm Hg in the standard-treatment group. During a median follow-up of 4.2 years, primary-outcome events (a composite of nonfatal stroke, nonfatal myocardial infarction, treatment or hospitalization for heart failure, or death from cardiovascular causes) occurred in 393 patients (1.65 events per 100 person-years) in the intensive-treatment group and 492 patients (2.09 events per 100 person-years) in the standard-treatment group (hazard ratio, 0.79). Fatal or nonfatal stroke, the most common type of cardiovascular disease among Chinese, occurred in 284 patients (1.19 events per 100 person-years) in the intensive-treatment group and in 356 patients (1.50 events per 100 person-years) in the standard-treatment group (hazard ratio, 0.79). The benefits of intensive BP control were consistent across all prespecified subgroups. The incidence of serious adverse events was similar in the groups. However, symptomatic hypotension and hyperkalemia occurred more frequently in the intensive-treatment group than in the standard-treatment group. The finding is consistent with some other trials and provides convincing evidence of the benefits of lowering SBP to a target of less than 120 mm Hg in T2D patients. The benefits of lowering SBP to a target of less than 120 mm Hg is known in patients without diabetes. Source: https://www.nejm.org/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.